The first in the industry! Huawei officially announced that it will launch a smart watch with blood sugar assessment on May 18.
On May 15th, Yu Chengdong posted on WeiboIt was announced on the Internet that the Huawei WATCH4 series will be the first to support high blood sugar risk assessment research. Yu Chengdong said that Huawei WATCH4 series users only need to authorize to join the research project, and after wearing the watch for some time, the watch will inform the high blood sugar risk level.
According to the plan, the Huawei WATCH 4 series will be officially unveiled at the press conference on May 18, and the blood sugar assessment function will be the highlight of the first experience in China.
In fact, as early as last month, a digital blogger broke the news that Huawei will launch a smart watch for non-invasive blood sugar monitoring - Watch 4, with a recognition rate of over 85%.
It is reported that this will be the world's first smart watch that supports blood sugar monitor ing.He has also been working hard on non-invasive blood sugar for several years, but he still hasn’t seen the product debut, and it has even been delayed for several years by the revelations. Foreign media person Mark Gurman believes that Apple’s non-invasive blood sugar products “will take at least three to seven years . time". In other words, Huawei's technology has been ahead of Apple for 7 years.
Consumer Electronics"Moonshot" technology in the field
Diabetes is a major human disease. According to data released by the International Diabetes Federation (IDF), approximately 537 million adults worldwide will suffer from diabetes in 2021, of which 6.7 million will die from diabetes. IDF expects the number of people with diabetes to rise to 643 million by 2030 and 783 million by 2045. For diabetic patients, high-frequency and accurate blood glucose monitoring is particularly important, and non-invasive continuous blood glucose measurement is imminent. Bloomberg compared it to a "moon landing" project.
In my country, the prevalence of diabetes has reached 11.2%, but the awareness rate of diabetes is low, only 36.5%. The Huawei WATCH 4 series can be carried around, allowing users to identify, intervene early, and take countermeasures as soon as possible.
Most of the blood glucose meters in the current market are finger blood glucose meters, which take blood samples by pricking fingers to detect the glucose content in human blood. Fingers need to be pricked every time blood is collected, causing harm to the human body, and there is a risk of infection, which is not suitable for daily frequent self-monitoring. Wearable devices with non-invasive blood sugar monitoring not only eliminate the pain of drawing blood but also can achieve 24-hour continuous monitoring.
Non-invasive blood glucose monitoring generally uses a laser transmitter to emit light of a specific wavelength into the interstitial fluid under the skin, and then the light returns to the sensor in the form of an indication of glucose concentration, storealize the detection of human blood glucose. It is reported that Apple uses a silicon photonic chip and a measurement process called "optical absorption spectroscopy".
Non-invasive blood sugar technology once set off a storm in A shares
Apple's non-invasive blood sugar monitoring began in the Jobs era, and the project has been researched continuously for 12 years. On February 23 this year, foreign media reported that Apple had made some major progress in the field of non-invasive blood sugar monitoring technology, with the goal of adding the blood sugar monitoring system to the Apple Watch (Apple Watch).
The news directly stimulated the surge in concept stocks related to A shares, among which Focuslight Technology Co., Ltd. The daily limit of 20cm, Fenda Technology10% daily limit, Lexin MedicalIt rose more than 14% at one point during the session. At the same time, "the first brother of domestic blood glucose meter" Sinocare Biotechnology Co., Ltd. It once fell more than 11% during the day.
The market prospect of continuous blood glucose monitoring is broad. According to China Insights Consulting, the scale of the continuous blood glucose monitoring (CGM) industry is expected to grow from US$5.7 billion in 2020 to US$36.5 billion in 2030 (corresponding to a compound growth rate of 20%), and the proportion of CGM in the blood glucose monitoring industry is expected to increase from 21% increased to 49%.
securitiesAccording to the incomplete statistics of the investor interaction platform, the Times·Databao mainly includes Focuslight Technology , Lexin Medical , Fenda Technology , and Yitong Technology.wait.
Focuslight Technology stated on the interactive platform that the micro-optical components of the parent company's silicon material can be used for infrared applications with a wavelength range of 1.2 μm to 7 μm. Apple's non-invasive blood sugar uses silicon photonic chip technology.
Lexin Medical stated on the interactive platform that the company focuses on medical-grade remote health monitoring equipment and services, and currently has a multi-dimensional sign monitoring product line in the field of health IoT, including smart blood glucose meters, smart electronic blood pressure monitors, heart stickers and other products. The company's smart wearable bracelets and watches, which have been mass-produced, have blood oxygen saturation monitoring functions.
Fenda technology in medical grade smart wearThe field has long-term R & D and manufacturing experience, and has the heart rate monitoring in the cloud state to reach the medical level. The company has a number of national patent technologies in the field of wearable and mobile medical care.
Goodix TechnologyIt said that it has independently developed a series of innovative technologies that improve the accuracy of blood oxygen detection and reduce power consumption, and have been widely commercialized in Xiaomi, OPPO, Xiaotiancai, Realme and other well-known wearable brand products.
Yitong Technology stated on the interactive platform that the company's self-developed PPG biosensor module can be used through the front-end LED of its optical AFE chip. It uses optical technology to accurately detect blood changes in microvessels, and with corresponding algorithms, it can realize ECG (electrocardiogram), blood oxygen, and blood pressure all-weather measurement.
Jiu'an MedicalFocusing on the R&D and production of health electronic products and smart hardware, the products cover personal health wearable devices in the fields of blood pressure, blood sugar, blood oxygen, ECG, heart rate, weight, body fat, sleep, and sports.